190 related articles for article (PubMed ID: 25556150)
1. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
[TBL] [Abstract][Full Text] [Related]
2. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Shirakami Y; Gottesman ME; Blaner WS
Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
[TBL] [Abstract][Full Text] [Related]
3. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
Michel C; Desdouets C; Slaoui M; Isaacs KR; Roberts RA; Boitier E
Toxicol Sci; 2007 Sep; 99(1):58-69. PubMed ID: 17602206
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
5. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
Stärkel P; Charette N; Borbath I; Schneider-Merck T; De Saeger C; Abarca J; Leclercq I; Horsmans Y
Mol Carcinog; 2012 Oct; 51(10):816-25. PubMed ID: 21882255
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis.
Nakamura M; Kitaura J; Enomoto Y; Lu Y; Nishimura K; Isobe M; Ozaki K; Komeno Y; Nakahara F; Oki T; Kume H; Homma Y; Kitamura T
Cancer Sci; 2012 Jan; 103(1):26-33. PubMed ID: 21943131
[TBL] [Abstract][Full Text] [Related]
7. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
[TBL] [Abstract][Full Text] [Related]
8. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
[TBL] [Abstract][Full Text] [Related]
10. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Rac1 GTPase contributes to liver-mediated basal immune homeostasis and LPS-induced endotoxemia.
Pohlmann S; Scheu S; Ziegler V; Schupp N; Henninger C; Fritz G
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1277-1292. PubMed ID: 29932987
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
13. Rac1 modulates acute and subacute genotoxin-induced hepatic stress responses, fibrosis and liver aging.
Bopp A; Wartlick F; Henninger C; Kaina B; Fritz G
Cell Death Dis; 2013 Mar; 4(3):e558. PubMed ID: 23519127
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
15. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
16. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
17. Tumor promotion in liver of mice with a conditional Cx26 knockout.
Marx-Stoelting P; Mahr J; Knorpp T; Schreiber S; Templin MF; Ott T; Buchmann A; Schwarz M
Toxicol Sci; 2008 Jun; 103(2):260-7. PubMed ID: 18308698
[TBL] [Abstract][Full Text] [Related]
18. The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine.
Agrawal A; Sharma M; Rai SK; Singh B; Tiwari M; Chandra R
Phytother Res; 2008 Sep; 22(9):1175-82. PubMed ID: 18729252
[TBL] [Abstract][Full Text] [Related]
19. Influence of CLOCK on cytotoxicity induced by diethylnitrosamine in mouse primary hepatocytes.
Matsunaga N; Kohno Y; Kakimoto K; Hayashi A; Koyanagi S; Ohdo S
Toxicology; 2011 Feb; 280(3):144-51. PubMed ID: 21167249
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
